2012, № 12 (148)

1. Bikbov M.M., Halimov A.R., Bikbova G.M. Бикбов М.М., Халимов А.Р., Бикбова Г.М. Ophthalmological measure for crosslinking. Patent for an invention RU №2412707 from 27.02.2011.

2. Kulikov S.N., Dolbin D.A., Tyurin Yu.A. Antibacterial features of low-molecular chitosan at atopic dermatitis.// Russian Allergological journal. 2008. — (suppl. 1): 146-147.

3. Slivkin A.I., Lapenko V.L., Arzamastsev A.P., Bolgov A.A. Aminoglucans as biological active components of medicinal agent// Vestnik VGU. 2005. — №2. — P. 73-87.

4. Slonimskiy A.Yu. Materials of research and practice confer. "Actual questions inflammatory eye diseases". Moscow, 2001. — P. 349-351.

5. Bozkir A., Saka О.М. Chitosan Nanoparticles for Plasmid DNA Delivery: Effect of Chitosan Molecular Structure on Formulation and Release Characteristics 2004. — Р. 107-112.

6. Chen C.L., Wang Y.M., Liu C.F., Wang J.Y. The effect of water-soluble chitosan on macrophage activation and the attenuation of mite allergen-induced airway inflammation // Biomaterials. 2008. — V.29: 2173-2182.

7. Wollensak G., Spoerl E., Seiler T. Riboflavin Ultravoilet-A-induced collagen crosslinking for the treatment of keratoconus //American J. Ophthalm. 2003. — Vol. 135.-№5. — P.620-626.

About this article